In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

ESC Heart Failure

Open-access research on all aspects of heart failure and its comorbidities: advancing knowledge about heart failure worldwide

 

ESC Heart Failure is the open access journal of the Heart Failure Association.

The journal improves the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as the clinical, social and population sciences all form part of the discipline that is heart failure.

Submit your paper

Fast Facts

  • Editor-in-Chief: Professor Piotr Ponikowski (PL)
  • Current volume: 11 (year 2025)
  • Issues per volume: 6
  • Impact Factor 2023 : 3.2

Editor-in-Chief History

Name Start Date End Date
Professor Stefan D. Anker 01/01/2014 31/08/2022
Professor Magnus Bäck (Interim Editor-in-Chief) 01/09/2022 31/03/2024
Professor Piotr Ponikowski  01/04/2024  
Updates on latest articles

Updates on latest articles

 

Receive the table of contents in your mailbox.

Track topics and authors important to you and receive articles in your mailbox.

For Authors

Before being published, all manuscripts go through double-blind, peer review by experienced international experts.

Most recent articles from ESC HF

09 Jan 2025
Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides
Author(s): Emmanuelle Berthelot, Tarek Laouar, Antoine Beurnier, Nataliya Hrynchynshyn, Jean Christophe Eicher, Jean‐Michel Tartière, Patrick Jourdain, Olivier Lairez, Barnabas Gellen
31 Dec 2024
Early genetic screening and cardiac intervention in patients with cardiomyopathies in a multidisciplinary clinic
Author(s): Chandu Sadasivan, Luke R. Gagnon, Deepan Hazra, Kaiming Wang, Erik Youngson, Jissy Thomas, Anita Y.M. Chan, D. Ian Paterson, Finlay A. McAlister, Tara Dzwiniel, Wayne Tymchak, Susan Christian, Gavin Y. Oudit
09 Jan 2025
Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different?
Author(s): Cristina Madaudo, Daniela Di Lisi, Antonio Cannatà, Federica Manfrè, Celeste Vullo, Marco Santoro, Ciro Botta, Salvatrice Mancuso, Sergio Siragusa, Alfredo Ruggero Galassi, Giuseppina Novo
28 Dec 2024
Prognostic role of high‐sensitivity cardiac troponin T in patients with cardiac sarcoidosis: insights from ILLUMINATE‐CS
Author(s): Yuichi Baba, Toru Kubo, Takeru Nabeta, Yuya Matsue, Takeshi Kitai, Yoshihisa Naruse, Tatsunori Taniguchi, Hidekazu Tanaka, Takahiro Okumura, Kenji Yoshioka, Hiroaki Kitaoka